Navigation Links
SIRO Clinpharm Strengthens its Clinical Trials Supplies Service Offering in India
Date:10/15/2009

MUMBAI, India, Oct. 15 /PRNewswire/ -- SIRO Clinpharm, a global Contract Research Organization (CRO) with its base in India, US, Europe and Israel, today announced expansion of its Clinical Trials Supplies facility in Mumbai, India. This expansion has been fueled by a demand by pharmaceutical and biotech companies for storage and distribution of clinical trial supplies. The facility is strategically located in Mumbai.

"We opened our clinical trials supplies warehouse in 2003 with a modest area of 1800 square feet," said Jayanti Vaidyanath, Vice President, Administration, Legal & Clinical Trials Supplies Management. "Those days we were one of the few CROs based out of India to have such a facility. Now, with the expanded facility, we have a bigger area of 6200 square feet with room for further expansion. We currently have two walk-in cold rooms at 2-8 degree storage, ambient storage at 15-25 degrees and storages for temperature ranges between -20 and -70 degrees. We have also significantly strengthened our inventory management process using the recently implemented Oracle Siebel CTMS tool," she added.

"The facility expansion will enable us to handle many more orders thus increasing our ability to serve a wider client base," said Dr. Ajit Nair, President, India Operations. "Very recently, we have partnered with a global leader in logistics to support them in Clinical Trials Supplies management in India. This broadens our scope by making us a part of their global storage and distribution network and increases the platform to work on for our international pharma and biotech clients," he added.

About SIRO: SIRO Clinpharm Private Limited (SIRO) is among one of the leading global Clinical Research Organizations (CROs), offering full scope services, conducting clinical trials in the Pharmaceutical, Biotechnology and Medical Devices sectors in compliance with International Standards. SIRO is one of the first CROs founded in India, which caters to the needs of pharmaceutical companies across the world. The company has offices in India, USA, Israel and in Europe in Germany, Romania, Estonia, Czech Republic and Greece. For more information, please visit our website - www.siroclinpharm.com.

SOURCE SIRO Clinpharm


'/>"/>
SOURCE SIRO Clinpharm
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SIRO ClinPharm and Advanced Clinical Trial Solutions Ink Strategic Alliance
2. Medpace Strengthens Presence in Central Europe
3. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
4. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
5. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
6. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
7. Anavex strengthens Board of Directors
8. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
9. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
10. JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
11. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseq™ ... developed with input from industry experts to ...
(Date:3/23/2017)... March 23, 2017  BioPharmX Corporation (NYSE MKT: ... the dermatology market, today reported financial results for ... and will provide an update on the company,s ... "We are pleased to report that ... BioPharmX," said President Anja Krammer. "We achieved key ...
(Date:3/23/2017)... , March 23, 2017 Kineta, Inc., ... of novel therapies in immuno-oncology, today announced the ... small molecule compounds that activate interferon response factor ... and demonstrate immune-mediated tumor regression in a murine ... study who demonstrated complete tumor regression to initial ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... animal blood plasma products and derivatives market is fragmented due to the ... large players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, ... clear leader, these three companies, collectively, held more than 76% of ... ...
Breaking Biology Technology:
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
(Date:3/20/2017)... Germany , March 20, 2017 At this ... Hamburg -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG ... is this year,s CeBIT partner country. At the largest German ... biometrics in use: fingerprint, face and iris recognition as well as DERMALOG´s ... ...
(Date:3/13/2017)... Germany , March 13, 2017 Future of security: ... ... DERMALOGs Face Matching enables to match face ... forms the basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for biometric ...
Breaking Biology News(10 mins):